Assertio Holdings (ASRT) Equity Average (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Equity Average came in at $84.8 million in Q1 2026, down 26.14% year-on-year from $114.8 million in Q1 2025, and down 15.1% quarter-over-quarter from $99.9 million in Q4 2025.
Assertio Holdings (ASRT) Equity Average (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Equity Average across 8 years of filings, most recently posting $84.8 million for Q1 2026.
- Equity Average for Q1 2026 came in at $84.8 million, down 26.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.8 million (down 26.14% YoY), and the FY2025 annual result was $107.5 million, down 17.0% from the prior year.
- Equity Average came in at $84.8 million for Q1 2026 at Assertio Holdings, down from $99.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $252.5 million in Q2 2023 to a low of $84.8 million in Q1 2026.
- The 5-year median for Equity Average is $131.3 million (2024), against an average of $143.9 million.
- Across the five-year window, Equity Average soared 122.32% in 2023 and sank 47.19% in 2024, its largest moves.
- Assertio Holdings' Equity Average stood at $180.3 million in 2022, then retreated by 8.25% to $165.4 million in 2023, then declined by 23.96% to $125.8 million in 2024, then dropped by 20.61% to $99.9 million in 2025, then slipped by 15.1% to $84.8 million in 2026.
- The last three Equity Average figures came in at $84.8 million (Q1 2026), $99.9 million (Q4 2025), and $99.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 84.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.79 Mn |
| Dec 31, 2025 | 99.88 Mn |
| Sep 30, 2025 | 99.55 Mn |
| Jun 30, 2025 | 100.91 Mn |
| Mar 31, 2025 | 114.81 Mn |
| Dec 31, 2024 | 125.80 Mn |
| Sep 30, 2024 | 131.34 Mn |
| Jun 30, 2024 | 133.32 Mn |
| Mar 31, 2024 | 136.25 Mn |
| Dec 31, 2023 | 165.44 Mn |
| Sep 30, 2023 | 223.57 Mn |
| Jun 30, 2023 | 252.47 Mn |
| Mar 31, 2023 | 238.19 Mn |
| Dec 31, 2022 | 180.32 Mn |
| Sep 30, 2022 | 131.64 Mn |
| Jun 30, 2022 | 120.12 Mn |
| Mar 31, 2022 | 107.14 Mn |
| Dec 31, 2021 | 99.64 Mn |
| Sep 30, 2021 | 94.56 Mn |
| Jun 30, 2021 | 98.78 Mn |